Mycoplasma Testing Market Size, Share, Growth Trends, and Industry Forecast

[priti sunil adsul]

The Mycoplasma Testing Market is evolving as pharmaceutical and biotechnology companies adopt faster and more automated contamination-detection technologies. Testing is essential for maintaining the quality of cell cultures and biological products used in research and manufacturing.

One of the most significant trends is the shift toward rapid molecular testing. PCR-based methods can significantly reduce the time required to identify contamination compared with conventional culture methods. Quantitative PCR has established a strong position because laboratories are familiar with the technology and validated workflows.

Digital PCR is another emerging technology. It can provide absolute quantification and is gaining attention for applications where high sensitivity is important. The increasing complexity of cell and gene therapy manufacturing could create additional demand for advanced molecular platforms.

Regulatory enforcement is another major market trend. Requirements surrounding contamination control and quality assurance encourage biopharmaceutical manufacturers to conduct routine testing at multiple manufacturing stages. This transforms mycoplasma detection into a recurring quality-control expenditure rather than an occasional laboratory activity.

The expansion of biologics and biosimilars is also supporting demand. As manufacturers increase production capacity, they require reliable testing procedures for cell banks, raw materials, in-process materials, and final products.

Automation is expected to become increasingly important. Automated sample preparation, amplification, data analysis, and reporting can improve laboratory productivity while reducing manual intervention.

Contract testing services are also gaining traction. Biotechnology companies without extensive internal laboratory infrastructure can outsource testing to specialized organizations with validated methods and experienced personnel.

According to MRFR, kits and reagents represent a leading product category, while testing services are expected to experience strong growth as outsourcing expands.

The industry outlook remains positive as pharmaceutical manufacturers continue investing in advanced biological therapies and stronger quality-control systems.

Frequently Asked Questions

What is a major market trend?
The migration from traditional culture testing toward rapid molecular methods is a major trend.

Why is PCR important?
PCR can provide faster detection and is widely used in biopharmaceutical quality-control workflows.

Is outsourcing increasing?
Yes. Contract testing is gaining importance as smaller companies seek specialized laboratory capabilities without major capital investments.